Cargando…

Vascular endothelial growth factor trap-eye and trap technology: Aflibercept from bench to bedside

Anti-vascular endothelial growth factor (VEGF) currently used to treat eye diseases have included monoclonal antibodies, antibody fragments, and an aptamer. A different method of achieving VEGF blockade in retinal diseases includes the concept of a cytokine trap. Cytokine traps technology are being...

Descripción completa

Detalles Bibliográficos
Autor principal: Al-Halafi, Ali M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220395/
https://www.ncbi.nlm.nih.gov/pubmed/25378873
http://dx.doi.org/10.4103/0974-620X.142591